维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="HANN D R"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The receptorlike kinase SERK3/BAK1 is a central regulator of innate immunity in plants 显示文摘	Heese A Hann D R Gimenez-Ibanez S	2007	Proc Natl Acad Sci USA2007，104，12：	1
2	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘	Perillo R Hann HW Mutimer D		0，，01：	1
3	Adefovir dipivoxil added to ongoing Lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘	Perrillo R Hann HW Mutimer D	2004	Gastroenterology2004，126，1：	1
4	A long-term study of the effects of antiviral therapy on survival of patients with HBV-associ- ated hepatocellular carcinoma(HCC) following local tumor abla- tion 显示文摘	Hann HW Coben R Brown D	2014	Cancer Med2014，3，2：	1
5	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘	Perrillo R Hann HW Mutimer D et aI	2004	Gastroenterology2004，126，1：	1
6	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘	Perrillo R Hann HW Mutimer D	2004	Gastroenterology2004，126，1：	1
7	VLSI applicaion to ESM processing显示文摘	Hann A C Cirucci J A Prunty D R	1987	IBM Technical Direction IBM Federal Systems Division Owego1987，13，1：	1
8	Ima- ging the aqueoushumor outflow pathway in human eyes by three-dimensional micro-computed tomography (3D micro- CT)显示文摘	HANN C R BENTLEY M D VERCNOCKE A	2011	ExpEye Res2011，92，2：	1
9	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis 13 virus显示文摘	Perrillo R Hann HW Mutimer D	2004	Gastroenterology2004，126，8：	1
10	Characterization specifications for baseline indirect drive NIF targets显示文摘	Stephens R B Hann S W Wilson D C	2002	Fusion Science and Tech-nology2002，41，1：	1
11	Some Studys on L-Glucoheptulose 显示文摘	Maclay W D Hann R M Hudson C S	1942	J Am Chem Soc1942，64，7：	1
12	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YM- DD mutant hepatitis B virus显示文摘	Perrillo R Hann HW Mutimer D	2004	Gastroenterology2004，126，1：	1
13	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus 显示文摘	PERRILLO R HANN H W MUTIMER D	2004	Gastroenterology2004，126，1：	1
14	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘	Perrillo R Hann HW Mutimer D	2004	Gastroenterology2004，126，1：	1
15	Adefovir dipivoxil added to ongoing Camivudine in chronic hepatitis B with YMDD mutant hepatitis B virus 显示文摘	Perrillo R Hann Hw Mutimer D	2004	Gastroenrology2004，126，1：	1
16	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘	Perrillo R Hann H W Mutimer D	2004	Gastroenterology2004，126，1：	1
17	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus 显示文摘	Perrillo R Hann HW Mutimer D	2004	Gastroenterology2004，126，1：	1
18	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus 显示文摘	Perrillo R Hann HW Mutimer D	2004	Gastroenterology2004，126，1：	1
19	Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus显示文摘	Perrillo R Hann HW Mutimer D	2004	Gastroenterology2004，126，14：	1
20	The receptor-like kinase SERK3/BAK1 is a central regulator of innate immunity in plants显示文摘	HEESE A HANN D R GIMENEZ-IBANEZ S	2007	Proceedings of the National Academy of Sciences2007，104，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示